A Dexamethasone Sparing-Regimen with Daratumumab and Lenalidomide in Frail Patients with Newly-Diagnosed Multiple Myeloma: Efficacy and Safety Analysis of the Phase 3 IFM2017-03 Trial

Authors :: Salomon Manier
Jill Corre
Cyrille Hulin
Kamel Laribi
Carla Araujo
Gian-Matteo Pica
Cyrille Touzeau
Pascal Godmer
Bohrane Slama
Lionel Karlin
Frederique Orsini-Piocelle
Mamoun Dib
Margaret Macro
Laurence Sanhes
Aurore Perrot
Jean Yves Mary
Jerome Lambert
Herve Avet-Loiseau
Philippe Moreau
Xavier Leleu
Thierry Facon
Source :: Blood. 140:1369-1370
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Full Text Access

Tools